Bariatric or metabolic surgery can significantly lower the risk of major cardiovascular events among patients with Type 2 diabetes and obesity, according to a new clinical study released at the European Society of Cardiology Congress in Paris. The retrospective study followed 13,722 Type 2 diabetes patients who underwent bariatric surgery to lose weight or metabolic […]
Structural Heart
Kaiser Permanente: Virtual cardiac rehab slashes secondary event rate
Kaiser Permanente yesterday touted promising results in reducing secondary cardiac events and rehospitalizations with a virtual cardiac rehabilitation program. Developed in collaboration with Samsung (LON:BC94), the Oakland, Calif.-based insurer’s eight-week program uses a Samsung smartwatch, paired with an Apple or Android smartphone, to send reminders for exercise, display heart rate and collect data, which is uploaded […]
Zoll loses bid to dismiss LifeVest lawsuit
A federal judge has denied Asahi Kasei (TYO:3407) subsidiary Zoll Medical’s motion to toss out a lawsuit filed by the family of a woman who attribute her death to a faulty Zoll LifeVest wearable defibrillator. U.S. District Court Judge Darrin Gayles in the Southern District of Florida also halted Zoll’s effort to bar evidence from the plaintiffs’ […]
Abiomed wins extended Medicare coverage for Impella
Abiomed (NSDQ:ABMD) has won a one-year reprieve from a proposed 27% Medicare reimbursement cut to hospitals for the use of its Impella ventricular support device. In April, the Centers for Medicare & Medicaid Services (CMS) floated the rate cut proposal for inpatient surgeries involving external assist devices inserted into the heart, such as Impella. The […]
Ancora Heart launches AccuCinch study in Europe
Ancora Heart said today that the first patient was enrolled in a European multi-center clinical evaluation of its AccuCinch ventricular repair system intended for treating patients with reduced ejection fraction systolic heart failure. The first patient was enrolled at Homolka Hospital in Prague, Czech Republic, by Dr. Petr Neužil, head of the hospital’s cardiology department […]
FDA slaps Abbott ICD recall with Class I label
The FDA has labeled a recent Abbott (NYSE:ABT) recall of Ellipse implantable cardioverter defibrillators (ICDs) as the most serious type, which could result in patient death. The company began the recall in June, citing damaged wires in 204 Ellipse pacemakers distributed globally. Today’s FDA announcement said that a faulty manufacturing process had left the Ellipse […]
Abiomed stock keeps on sliding
Abiomed (NSDQ:ABMD) shares continued to plummet today following a tough earnings report, closing down -26.45% to $204.87 each. The Danvers, Mass.-based medical device maker reported fiscal first-quarter sales that missed the mark and lowered its top-line outlook on the rest of the year. Abiomed posted profits of $88.9 million, or $1.93 per share, on sales […]
Abiomed plunges on fiscal Q1 earnings miss, lowered outlook
Abiomed (NSDQ:ABMD) shares came under pressure today after the medical device maker reported fiscal first-quarter sales that missed the mark and lowered its top-line outlook on the rest of the year. Danvers, Mass.-based Abiomed posted profits of $88.9 million, or $1.93 per share, on sales of $207.7 million for the three months ended June 3o, […]
Magenta Medical gets funding from U.S.-based VC firm
Miniature heart pump developer Magenta Medical said today that New Enterprise Associates (NEA) has led a financing round for an undisclosed sum. The NEA group includes existing investors such as Pitango Venture Capital and JVC Investment Partners as well as a group of private investors led by Dr. Jacques Seguin, co-founder of ReCor Medical and […]
Getinge recalls cardiac pumps following reports of 5 deaths
Getinge (STO:GETI-B) is recalling four models of Maquet/Datascope intra-aortic balloon pumps (IABP) due to reports of faulty batteries. Five deaths have been reported since March 2016. The IABP batteries failed to hold a charge, stopped unexpectedly, or had a shortened run-time, which may have caused the device to stop working when being operated by battery […]
Medtronic touts stroke data from HeartWare HVAD thoracotomy study
Medtronic (NYSE:MDT) today touted stroke data from the Lateral trial of its HeartWare HVAD left ventricular assist device involving implantation via thoracotomy instead of open surgery. With a thoracotomy implantation, surgeons insert the pump via a small, lateral incision between the left ribs and make a second small incision to accommodate the pump’s outflow graft. […]
